Connect with us

Technology

AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities

Published

on

New AI model enables ChemPass AI for Ag™ to identify and prioritize antifungal molecules with a higher probability of biological success at early discovery stages

REHOVOT, Israel, July 15, 2026 /PRNewswire/ — AgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced the launch of its Antifungal Potency Predictor (APP). This new machine learning model predicts the antifungal potency of small molecules directly from their chemical structures, expanding the capabilities of Evogene’s ChemPass AI for Ag™ platform by forecasting biological efficacy prior to chemical synthesis and fungal assay validation.

 

The global fungicide market is estimated at approximately $22[1] billion annually. Fungal diseases cause significant crop loss worldwide, resulting in tens of billions of dollars in economic damage each year and posing a growing threat to global food security[2]. Concurrently, the widespread and repetitive use of existing fungicides has accelerated the emergence of resistant fungal pathogens, diminishing the long-term efficacy of many commercial products. As resistance continues to spread, the agriculture industry faces an urgent need for novel fungicides with innovative modes of action (MoAs) and distinct chemical structures.

The APP model, developed using advanced machine learning algorithms trained on AgPlenus’ proprietary curated datasets, represents a significant milestone in the company’s AI-driven fungicide discovery capabilities. Building upon the proven success of the ChemPass AI for Ag™ platform in identifying novel crop protection targets and generating molecules with high target-protein affinity, the new model further extends these capabilities to predict the small molecule activity within the fungus itself.

By forecasting antifungal potency during the earliest discovery phases, the model enables highly informed decision-making prior to chemical synthesis and biological testing. This approach significantly reduces the number of molecules requiring experimental evaluation, focusing resources on candidates with the highest probability of downstream development success and accelerating the discovery of next-generation fungicides.

The launch of the APP model is expected to support and advance AgPlenus’ internal fungicide pipeline, which includes promising targets such as APTF-1. This target is designed to combat devastating global crop diseases, including Septoria Wheat Blotch. Additionally, the model is expected to contribute to planned pipeline expansions targeting other critical pathogens, such as Botrytis and Fusarium.

Beyond its immediate application in accelerating current and future product development, the APP model lays the groundwork for additional predictive AI models that AgPlenus and Evogene plan to co-develop, aiming to forecast other critical biological attributes throughout the crop protection discovery process.

Dr. Dan J. Gelvan, CEO of AgPlenus, commented: “In 2025, we demonstrated the power of the ChemPass AI for Ag™ platform to identify novel target proteins capable of overcoming resistance, as well as novel active small molecules combating devastating crop diseases like Septoria wheat blotch. Today, we are taking another major step forward with the launch of our Antifungal Potency Predictor. By enabling us to forecast antifungal potency directly from molecular structure, prior to chemical synthesis, the APP model allows us to identify and prioritize high-quality candidates at the earliest stages of discovery. I am excited to see this breakthrough model integrated into ChemPass AI for Ag™, further strengthening our ability to advance current and future product development programs.”

[1] Based on Company’s calculations.
[2] https://www.mpg.de/23545750/plants-fungal-diseases 

About Evogene Ltd.

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) is a pioneering company in computational chemistry specializing in the generative design of small molecules for drug development and ag-chemical products. At the core of its technology is ChemPass AI™ a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.

For more information, please visit www.evogene.com.

About AgPlenus Ltd.

AgPlenus, a subsidiary of Evogene, is a platform company designing effective and sustainable crop protection products. At AgPlenus, we are solving pesticide resistance by infusing the discovery process with predictive biology and artificial intelligence. AgPlenus leverages the ChemPass AI™ tech-engine, licensed by Evogene, to discover and bring to market effective and sustainable crop protection products. Our target-based approach allows us to reduce risk and increase efficiency, so that we can deliver on our promise to defeat global pesticide resistance.

For more information, please visit www.agplenus.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 relating to future events. These statements may be identified by words such as “may,” “could,” “expects,” “hopes,” “intends,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates,” “demonstrates”, “designed to,” “intended to,” “with the goal of,” or words of similar meaning. For example, Evogene and its subsidiaries use forward-looking statements in this press release when it discusses: the Antifungal Potency Predictor’s ability to forecast biological efficacy prior to chemical synthesis and fungal assay validation and to predict the small molecule activity within the fungus itself, the ability to reduce the number of molecules requiring experimental evaluation, focusing resources on candidates with the highest probability of downstream development success and accelerating the discovery of next-generation fungicides, the new model’s contribution to planned pipeline expansions and APP model ability to lay the groundwork for additional predictive AI models. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene and its subsidiaries may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which are beyond the control of Evogene and its subsidiaries, including, without limitation, the aftermath of the recent war between Israel and each of (i) the terrorist groups, Hamas and Hezbollah, (ii) Iran, and (iii) other regional terrorist groups supported by Iran, and any potential destabilizations in Israel, neighboring territories or the Middle East region, and those risk factors contained in Evogene’s reports filed with the applicable securities authority. In addition, Evogene and its subsidiaries rely, and expect to continue to rely, on third parties to conduct certain activities, such as their and pre-clinical studies, and if these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected deadlines, Evogene and its subsidiaries may experience significant delays in the conduct of their activities. Evogene and its subsidiaries disclaim any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.

Investor Relations Contact:

ir@evogene.com
Tel: +972-8-9311901

Logo: https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
Logo: https://mma.prnewswire.com/media/1334691/AgPlenus_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/agplenus-launches-novel-ai-model-for-predicting-antifungal-potency-expanding-chempass-ai-for-ag-capabilities-302826355.html

SOURCE AgPlenus Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CISOs Connect™ Opens Submissions for the 2026 CISO Choice Awards™, Recognizing Excellence in Cybersecurity

Published

on

By

Independent awards program judged by a global board of practicing CISOs recognizes cybersecurity companies delivering outstanding innovation, measurable business value, and meaningful enterprise impact.

NEW YORK, July 15, 2026 /PRNewswire/ — CISOs Connect™, the global community of Chief Information Security Officers (CISOs), today announced that submissions are open for the 2026 CISO Choice Awards™.

The CISO Choice Awards™ recognize the cybersecurity companies that have earned the trust of the executives responsible for protecting today’s enterprises. The program celebrates organizations whose technologies help security leaders better manage risk, strengthen resilience, and enable their businesses.

“The companies that stand out are the ones that consistently deliver meaningful outcomes for the organizations they serve,” said Stephen Bennett, Group CISO, Domino’s Pizza Enterprises Ltd., and Judge, CISO Choice Awards™. “They combine innovation with operational excellence and help security leaders better protect their businesses. That’s what the CISO Choice Awards™ recognize.”

Every submission is independently evaluated by a global board of practicing CISOs representing enterprise organizations across North America, Europe, and Asia-Pacific. Collectively, the judges bring decades of experience protecting and enabling some of the world’s leading businesses. Entries are evaluated using consistent judging criteria focused on innovation, business value, operational effectiveness, enterprise impact, and measurable outcomes.

“Every day, CISOs are making decisions about the technologies they trust to protect their businesses,” said David Cass, President, CISOs Connect™, and CISO, Keyrock. “The CISO Choice Awards™ recognize the companies that have earned that trust through innovation, execution, and measurable results, while ensuring the voice of the executive practitioner helps shape our industry.”

The 2026 Global Board of Judges includes:

Reuben Athaide, Head of Innovation, Application Security & Assurance, Standard Chartered — SingaporeStephen Bennett, Group CISO, Domino’s Pizza Enterprises Ltd. — AustraliaVlad Brodsky, SVP, CIO & CISO, OTC Markets Group — United StatesNikki Gilbert, Global CISO, RWE AG — GermanyChatchawarn Jirupathum, Group Information Security & Data Protection Officer, RMA Group — ThailandHugo Lai, CISO, Temple University Health System — United StatesLock Langdon, VP, Enterprise Technology & CISO, Aprio — United StatesBrian Miller, CISO, Healthfirst — United StatesJamaine Mungo, CISO, Philadelphia International Airport — United StatesPriya Mouli, CISO, University of Alberta — CanadaNashira Spencer, CISO, Stitch Fix — United StatesHussein Syed, SVP & CISO, RWJBarnabas Health — United States

“Recognition from CISOs carries a unique level of credibility because it reflects real-world experience and accountability,” said Hussein Syed, SVP & CISO, RWJBarnabas Health, and Judge, CISO Choice Awards™. “These awards recognize organizations that consistently help enterprises reduce risk, strengthen resilience, and achieve better business outcomes.”

The 2026 CISO Choice Awards™ recognize excellence across premier company honors and solution categories spanning today’s most critical areas of cybersecurity. Finalists will be announced on August 20th, 2026, and winners will be recognized during the CISO Choice Awards™ Gala on October 15, 2026, just outside Washington, D.C.

Submissions are now open. Organizations interested in participating can learn more about award categories, eligibility requirements, and judging criteria at [website].

Submit your entry: https://cisosconnect.awardsplatform.com

About CISOs Connect™

CISOs Connect™ is an invitation-only community of global CISOs dedicated to advancing the cybersecurity profession through executive collaboration, independent research, leadership development, and industry recognition. Through executive forums, research initiatives, leadership programs, and awards programs, including the CISO Choice Awards™, CISOs Connect™ elevates the collective judgment and experience of executive cybersecurity practitioners while helping shape the future of enterprise security.

Media Contact
Amanda Ortiz
1-438-270-1731
418807@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisos-connect-opens-submissions-for-the-2026-ciso-choice-awards-recognizing-excellence-in-cybersecurity-302826462.html

SOURCE CISOs Connect

Continue Reading

Technology

PROSUS N.V. ANNOUNCES RESULTS OF CASH TENDER OFFERS FOR ITS 4.850% NOTES DUE 2027 AND 3.257% NOTES DUE 2027

Published

on

By

AMSTERDAM, July 15, 2026 /PRNewswire/ — Prosus N.V. (the “Company”), a public company with limited liability (naamloze vennootschap)under the laws of the Netherlands, with its corporate seat (statutaire zetel) in Amsterdam, the Netherlands, announced today the results of its previously announced cash tender offers (the “Offers”) for its outstanding 4.850% Notes due 2027 (the “Any and All Notes”) and its outstanding 3.257% Senior Notes due 2027 (the “Capped Tender Offer Notes”).

The Offers were made upon and are subject to the terms and conditions set forth in the Offer to Purchase dated July 6, 2026 (the “Offer to Purchase”). Capitalized terms used in this announcement but not defined herein have the meanings given to them in the Offer to Purchase.

The Offers expired at 5:00 p.m. (New York City time) on July 14, 2026 (the “Expiration Date”).

Title of
Security

CUSIP/ISIN

Maturity
Date

Principal Amount
Outstanding(1)

Principal
Amount
Tendered(2)

Principal
Amount
Accepted

Total
Consideration(3)

4.850% Notes due 2027 (the “Any and All Notes”)

62856R AD7 / US62856RAD70

N5946F AD9/ USN5946FAD98

July 6, 2027

U.S.$614,146,000

U.S.$157,029,000

U.S.$157,029,000

U.S.$1,002.31

3.257% Senior Notes due 2027 (the “Capped Tender Offer Notes”)

74365P AG3 / US74365PAG37

N7163R AW3/ USN7163RAW36

January 19, 2027

U.S.$1,000,000,000

U.S.$462,045,000

U.S.$462,045,000

U.S.$994.50

__________________________
Notes:

As of the commencement date of the Offers. Notes validly tendered on or before the Expiration Date. Per U.S.$1,000 principal amount of Notes validly tendered and accepted for purchase pursuant to the Offers.

The Company was advised by the Information and Tender Agent that as of the Expiration Date, the aggregate principal amount of each of the Any and All Notes and the Capped Tender Offer Notes specified in the table above was validly tendered and not validly withdrawn. The table above provides the aggregate principal amount of each of the Any and All Notes and the Capped Tender Offer Notes that the Company has accepted in the Offers on the terms and subject to the conditions set forth in the Offer to Purchase. No Scaling Factor has been applied in the Capped Tender Offer.

Payment of the applicable Total Consideration for all Notes validly tendered and accepted for purchase by the Company pursuant to the Offers will be made on July 16, 2026 (the “Settlement Date”). In addition to the Total Consideration as set forth in the table above, all Holders whose Notes are validly tendered and accepted for purchase will also receive accrued and unpaid interest on such Notes from, and including, the applicable last interest payment date up to, but not including, the Settlement Date, payable on the Settlement Date.

All Notes accepted for purchase in the Offers will be cancelled and retired, and will no longer remain outstanding obligations of the Company.

The Company has elected to exercise its optional redemption right in respect of any outstanding Any and All Notes following settlement of the Any and All Tender Offer, in accordance with the terms and conditions of the Any and All Notes, and issued a notice of redemption on July 9, 2026. Accordingly, Holders of Any and All Notes who did not tender their notes in the Any and All Tender Offer will have their notes redeemed on August 10, 2026 at the applicable make-whole redemption price calculated in accordance with the terms and conditions of the Any and All Notes, which may be higher or lower than the Total Consideration for the Any and All Notes. Nothing in this announcement constitutes a redemption notice.

FURTHER INFORMATION

The Offer to Purchase sets out the full terms of the Offers. The Offer to Purchase and any other relevant notice and documents with respect to the Offers are available at https://clients.dfkingltd.com/prosus, operated by the Information and Tender Agent for the purpose of the Offers, and from the Information and Tender Agent at the telephone number or e-mail address set out below. Holders may also contact the Dealer Managers at the telephone numbers or addresses set out below for information concerning the Offers. Holders may also contact their broker, dealer, commercial bank or trust company or other nominee for assistance concerning the Offers.

DEALER MANAGERS

Goldman Sachs & Co. LLC

BNP Paribas Securities Corp.

787 Seventh Avenue

New York, NY 10119

United States of America

Attention: Liability Management Group

Telephone:

In the United States:

+1 (888) 210-4358 (toll-free)

+1 (212) 841-3059 (collect)

In Europe:

+33 1 55 77 78 94

Email: liability.management@bnpparibas.com

BofA Securities Europe SA

51 rue La Boétie

75008 Paris

France

Attention: Liability Management Group

Telephone:

In the United States:

+1 (888) 292-0070 (toll-free)

+1 (980) 387-3907 (collect)

 In Europe:

 +33 1 877 01057

Email: DG.LM-EMEA@bofa.com

200 West Street

New York, NY 10282-2198

United States of America

Attention: Liability Management Group

Telephone:

In the United States:

+1 (800) 828-3182 (toll-free)

+1 (212) 357-1452 (collect)

In Europe:

+44 207 774 4836

Email:

liabilitymanagement.eu@gs.com

THE INFORMATION AND TENDER AGENT

D.F. King

In New York:

28 Liberty Street, 53rd Floor

New York, NY 10005, USA

Banks and brokers call:

(646) 677-2521

All others call toll free:

(800) 967-5051

E-mail: prosus@dfkingltd.com

In London:

51 Lime Street, London

EC3M 7DQ, United Kingdom

Banks and brokers call:

+44 20 7920 9700

Offer Website: https://clients.dfkingltd.com/prosus

NOTICE AND DISCLAIMER

This announcement is for informational purposes only and is not an offer to purchase or a solicitation of an offer to purchase with respect to any Notes. The terms and conditions of the Offers are described in the Offer to Purchase. This announcement must be read in conjunction with the Offer to Purchase.

This announcement contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the Market Abuse Regulation (EU) 596/2014.

OFFER AND DISTRIBUTION RESTRICTIONS

General

The distribution of this announcement and the Offer to Purchase in certain jurisdictions may be restricted by law. Persons into whose possession this announcement or the Offer to Purchase comes are required by the Company, the Dealer Managers and the Information and Tender Agent to inform themselves of and to observe any such restrictions.

Neither this announcement nor the Offer to Purchase constitutes, nor may they be used in connection with, an offer to buy Notes or a solicitation to sell Notes by anyone in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such an offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make an offer or a solicitation. Neither the Company, the Dealer Managers nor the Information and Tender Agent accepts any responsibility for any violation by any person of the restrictions applicable in any jurisdiction.

European Economic Area

The Offers are not being made in any Member State of the European Economic Area, other than to persons who are “qualified investors” as defined in Regulation (EU) No 2017/1129 (as amended, the “Prospectus Regulation”), or in other circumstances falling within Article 1(4) of the Prospectus Regulation. This EEA selling restriction is in addition to any other selling restrictions set out in the Offer to Purchase.

United Kingdom

The communication of this announcement and the Offer to Purchase by the Company and any other documents or materials relating to the Offers is not being made, and such documents and/or materials have not been approved, by an authorized person for the purposes of section 21 of the Financial Services and Markets Act 2000 (the “FSMA”), as amended. Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of such documents and/or materials as a financial promotion is only being made to persons outside the United Kingdom and those persons in the United Kingdom falling within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”)), persons who are within Article 43(2) of the Order, persons who are qualified investors of the kind described in Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.), and persons who otherwise fall within an exemption set forth in the Order such that section 21(1) of the FSMA does not apply or any other persons to whom the Offers may otherwise lawfully be made under the Order and all other applicable securities laws.

Italy

None of the Offers, the Offer to Purchase or any other document or materials relating to the Offers have been or will be submitted to the clearance procedures of the Commissione Nazionale per le Società e la Borsa (“CONSOB”) pursuant to Italian laws and regulations. The Offers are being carried out in Italy as exempted offers pursuant to article 101-bis, paragraph 3-bis of the Legislative Decree No. 58 of 24 February 1998, as amended (the “Financial Services Act”) and article 35-bis, paragraph 4 of CONSOB Regulation No. 11971 of 14 May 1999, as amended. Holders or beneficial owners of the Notes that are located in Italy can tender Notes for purchase in the Offers through authorized persons (such as investment firms, banks or financial intermediaries permitted to conduct such activities in the Republic of Italy in accordance with the Financial Services Act, CONSOB Regulation No. 16190 of 29 October 2007, as amended from time to time, and Legislative Decree No. 385 of 1 September 1993, as amended) and in compliance with applicable laws and regulations or with requirements imposed by CONSOB or any other Italian authority.

Each intermediary must comply with the applicable laws and regulations concerning information duties vis-à-vis its clients in connection with the Notes and/or the Offers.

France

The Offers are not being made, directly or indirectly, to the public in the Republic of France (“France”). Neither this announcement nor the Offer to Purchase nor any other document or material relating to the Offers has been or shall be distributed to the public in France and only (i) providers of investment services relating to portfolio management for the account of third parties (personnes fournissant le service d’investissement de gestion de portefeuille pour compte de tiers) and/or (ii) qualified investors (investisseurs qualifiés), acting for their own account, with the exception of individuals, within the meaning ascribed to them in, and in accordance with, Articles L.411-1, L.411-2 and D.411-1 of the French Code monétaire et financier, and applicable regulations thereunder, are eligible to participate in the Offers. This announcement, the Offer to Purchase and any other documents or offering materials relating to the Offers have not been and will not be submitted for clearance to nor approved by the Autorité des Marchés Financiers.

Belgium

Neither this announcement nor the Offer to Purchase nor any other documents or materials relating to the Offers have been submitted to or will be submitted for approval or recognition to the Belgian Financial Services and Markets Authority (Autoriteit voor financiële diensten en markten / Autorité des services et marchés financiers) and, accordingly, the Offers may not be made in Belgium by way of a public offering, as defined in Articles 3 and 6 of the Belgian Law of 1 April 2007 on public takeover bids as amended or replaced from time to time. Accordingly, the Offers may not be advertised and the Offers will not be extended, and neither this announcement nor the Offer to Purchase nor any other documents or materials relating to the Offers (including any memorandum, information circular, brochure or any similar documents) have been or shall be distributed or made available, directly or indirectly, to any person in Belgium other than “qualified investors” in the sense of Article 10 of the Belgian Law of 16 June 2006 on the public offer of placement instruments and the admission to trading of placement instruments on regulated markets, acting on their own account. Insofar as Belgium is concerned, this announcement and the Offer to Purchase have been issued only for the personal use of the above qualified investors and exclusively for the purpose of the Offers. Accordingly, the information contained in this announcement and the Offer to Purchase may not be used for any other purpose or disclosed to any other person in Belgium.

South Africa

The communication of this announcement and the Offer to Purchase by the Company and any other documents or materials relating to the Offers should not be construed as constituting any form of investment advice or recommendation, guidance or proposal of a financial nature under the South African Financial Advisory and Intermediary Services Act, 37 of 2002 (as amended or re-enacted). The Offers are not being made to and do not constitute an “offer to the public” (as such term is defined in the South African Companies Act, 71 of 2008 (the “SA Companies Act”)) and the Offer to Purchase is not, nor is it intended to constitute, a “registered prospectus” (as such term is defined in the SA Companies Act) prepared and registered under the SA Companies Act.

View original content:https://www.prnewswire.com/news-releases/prosus-nv-announces-results-of-cash-tender-offers-for-its-4-850-notes-due-2027-and-3-257-notes-due-2027–302826464.html

SOURCE Prosus N.V.

Continue Reading

Technology

Instacart to Report Second Quarter 2026 Financial Results on August 6, 2026

Published

on

By

SAN FRANCISCO, July 15, 2026 /PRNewswire/ — Instacart (NASDAQ: CART) today announced it will report its second quarter 2026 financial results after market close on Thursday, August 6, 2026.

Instacart management will also host a conference call to discuss the company’s results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Thursday, August 6, 2026. To access a live webcast of the call, please visit Instacart’s Investor Relations website at https://investors.instacart.com. After the call concludes, a replay will be made available on Instacart’s Investor Relations website.

Instacart uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Instacart’s Investor Relations website, press releases, SEC filings, public conference calls, and public webcasts, in addition to following Instacart’s blog at www.instacart.com/company/blog.

About Instacart
Instacart is a leading grocery technology company that partners with more than 2,200 retail banners – representing nearly 100,000 stores – to transform how people shop for the groceries they need from the retailers they trust, while creating flexible earning opportunities for shoppers. Through the Instacart Marketplace, Instacart Enterprise platform, and Instacart Ads ecosystem, the company powers ecommerce, fulfillment, in-store technology, AI offerings, and advertising for partners. For more information, visit www.instacart.com/company. Maplebear Inc. is the registered corporate name of Instacart.

View original content to download multimedia:https://www.prnewswire.com/news-releases/instacart-to-report-second-quarter-2026-financial-results-on-august-6-2026-302825559.html

SOURCE Maplebear Inc. dba Instacart

Continue Reading

Trending